Dhruva SS, Parzynski CS, Gamble GM, Curtis JP, Desai NR, Yeh RW, Masoudi FA, Kuntz R, Shaw RE, Marinac-Dabic D et al..
2020.
Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data.. J Am Heart Assoc. 9(4):e013606.
Pandya A, Soeteman DI, Gupta A, Kamel H, Mushlin AI, Rosenthal MB.
2020.
Can Pay-for Performance Incentive Levels be Determined Using a Cost-Effectiveness Framework? Circ Cardiovasc Qual Outcomes. 13(7):e006492.
Wirrell EC, Grinspan ZM, Knupp KG, Jiang Y, Hammeed B, Mytinger JR, Patel AD, Nabbout R, Specchio N, J Cross H et al..
2020.
Care Delivery for Children With Epilepsy During the COVID-19 Pandemic: An International Survey of Clinicians.. J Child Neurol. :883073820940189.
Su C, Xu Z, Pathak J, Wang F.
2020.
Deep learning in mental health outcome research: a scoping review.. Transl Psychiatry. 10(1):116.
Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al..
2020.
Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)
Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al..
2020.
Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..
2020.
Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.